May 11-14, 2026
Hynes Convention CenterBoston, MA Yana Reshetnyak, PhDPresident & Chief Executive Officer at pHLIPSpeaker
Profile
Dr. Yana Reshetnyak is a co-founder and CEO of pHLIP, Inc. She drives the discovery, development, and clinical translation of pHLIP-targeted technology for delivering therapeutic and imaging agents. pHLIP-agents currently are under testing in Phase I/II clinical trials. Dr. Reshetnyak has co-authored more than 100 publications and is a co-inventor on numerous patents. Dr. Reshetnyak obtained her MS in Physics at Saint-Petersburg University, her PhD in Biophysics at the Russian Academy of Sciences and completed her postdoctoral training at Yale University.
Agenda Sessions
Novel e-pHLIP Technology for Cytoplasmic Delivery of Polar Molecules
, 2:00pmView Session